Research Grants

Funding Agency:
Marsha Rivkin Center for Ovarian Cancer Research

Each year, the Marsha Rivkin Center funds promising research for ovarian cancer. These studies and researchers are selected through a highly competitive process. Each application is individually reviewed by a panel of nationally recognized experts for its scientific merit, novelty, and potential to impact the prevention, detection, treatment, and understanding of the disease. There are multiple streams of scientific funding:


Pilot Study Program: One-year awards at $75,000 each, Pilot Study Program awards will support investigator-initiated projects in all areas of ovarian cancer research. In addition, projects designed to analyze data from already funded clinical trials will be considered. Deadline: Dec. 1, 2023

Scientific Scholar Award: Two-year grants at $120,000 each, Scientific Scholar Awards are intended to assist promising laboratory and clinical scientists in pursuing a career as an independent investigator in ovarian cancer research. Deadline: TBA

Bridge Funding Award: Bridge Funding allows researchers to produce data needed to substantiate their proposal resubmission to federal funding agencies for a promising new research project. The Rivkin Center provides interim funding of up to $30,000 to researchers who have submitted an R01 or R21 proposal to the National Institutes of Health (NIH) or an original proposal to the Department of Defense (DoD) pertaining to ovarian cancer and who have not received, but were close to, a fundable score. Deadlines: May 1; Oct. 15

Agency Website

Funding Type



Junior Faculty
Medical Fellow/Resident


Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

October 15, 2023